S&P 500   4,604.37
DOW   36,247.87
QQQ   392.17
Dozens of animals taken from Virginia roadside zoo as part of investigation
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity (Ad)
Military-themed brewery wants to open in a big Navy town. An ex-SEAL is getting in the way
Elon Musk restores X account of conspiracy theorist Alex Jones
Trading Experts Call It “The Perfect Tesla Trade” (Ad)
Consumer product agency issues warning on small magnetic balls linked to deaths
At UN climate talks, cameras are everywhere. Many belong to Emirati company with a murky history
Trading Experts Call It “The Perfect Tesla Trade” (Ad)
Cows in Rotterdam harbor, seedlings on rafts in India; are floating farms the future?
Agriculture gets its day at COP28, but experts see big barriers to cutting emissions
S&P 500   4,604.37
DOW   36,247.87
QQQ   392.17
Dozens of animals taken from Virginia roadside zoo as part of investigation
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity (Ad)
Military-themed brewery wants to open in a big Navy town. An ex-SEAL is getting in the way
Elon Musk restores X account of conspiracy theorist Alex Jones
Trading Experts Call It “The Perfect Tesla Trade” (Ad)
Consumer product agency issues warning on small magnetic balls linked to deaths
At UN climate talks, cameras are everywhere. Many belong to Emirati company with a murky history
Trading Experts Call It “The Perfect Tesla Trade” (Ad)
Cows in Rotterdam harbor, seedlings on rafts in India; are floating farms the future?
Agriculture gets its day at COP28, but experts see big barriers to cutting emissions
S&P 500   4,604.37
DOW   36,247.87
QQQ   392.17
Dozens of animals taken from Virginia roadside zoo as part of investigation
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity (Ad)
Military-themed brewery wants to open in a big Navy town. An ex-SEAL is getting in the way
Elon Musk restores X account of conspiracy theorist Alex Jones
Trading Experts Call It “The Perfect Tesla Trade” (Ad)
Consumer product agency issues warning on small magnetic balls linked to deaths
At UN climate talks, cameras are everywhere. Many belong to Emirati company with a murky history
Trading Experts Call It “The Perfect Tesla Trade” (Ad)
Cows in Rotterdam harbor, seedlings on rafts in India; are floating farms the future?
Agriculture gets its day at COP28, but experts see big barriers to cutting emissions
S&P 500   4,604.37
DOW   36,247.87
QQQ   392.17
Dozens of animals taken from Virginia roadside zoo as part of investigation
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity (Ad)
Military-themed brewery wants to open in a big Navy town. An ex-SEAL is getting in the way
Elon Musk restores X account of conspiracy theorist Alex Jones
Trading Experts Call It “The Perfect Tesla Trade” (Ad)
Consumer product agency issues warning on small magnetic balls linked to deaths
At UN climate talks, cameras are everywhere. Many belong to Emirati company with a murky history
Trading Experts Call It “The Perfect Tesla Trade” (Ad)
Cows in Rotterdam harbor, seedlings on rafts in India; are floating farms the future?
Agriculture gets its day at COP28, but experts see big barriers to cutting emissions

Medtronic (MDT) Competitors

$79.35
-0.20 (-0.25%)
(As of 12/8/2023 ET)
Compare
Today's Range
$79.28
$79.85
50-Day Range
$69.43
$79.99
52-Week Range
$68.84
$92.02
Volume
6.24 million shs
Average Volume
6.22 million shs
Market Capitalization
$105.51 billion
P/E Ratio
25.85
Dividend Yield
3.48%
Price Target
$93.33

MDT vs. BMY, ISRG, SYK, GILD, ELV, SNY, VRTX, REGN, ZTS, and BSX

Should you be buying Medtronic stock or one of its competitors? The main competitors of Medtronic include Bristol-Myers Squibb (BMY), Intuitive Surgical (ISRG), Stryker (SYK), Gilead Sciences (GILD), Elevance Health (ELV), Sanofi (SNY), Vertex Pharmaceuticals (VRTX), Regeneron Pharmaceuticals (REGN), Zoetis (ZTS), and Boston Scientific (BSX). These companies are all part of the "medical" sector.

Medtronic vs.

Bristol-Myers Squibb (NYSE:BMY) and Medtronic (NYSE:MDT) are both large-cap medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their community ranking, risk, profitability, institutional ownership, earnings, valuation, media sentiment, dividends and analyst recommendations.

Bristol-Myers Squibb has higher revenue and earnings than Medtronic. Bristol-Myers Squibb is trading at a lower price-to-earnings ratio than Medtronic, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Bristol-Myers Squibb$46.16B2.22$6.33B$3.9412.77
Medtronic$31.23B3.38$3.76B$3.0725.85

In the previous week, Bristol-Myers Squibb had 4 more articles in the media than Medtronic. MarketBeat recorded 24 mentions for Bristol-Myers Squibb and 20 mentions for Medtronic. Medtronic's average media sentiment score of 0.89 beat Bristol-Myers Squibb's score of 0.68 indicating that Bristol-Myers Squibb is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Bristol-Myers Squibb
13 Very Positive mention(s)
2 Positive mention(s)
3 Neutral mention(s)
2 Negative mention(s)
2 Very Negative mention(s)
Positive
Medtronic
7 Very Positive mention(s)
3 Positive mention(s)
4 Neutral mention(s)
2 Negative mention(s)
0 Very Negative mention(s)
Positive

75.0% of Bristol-Myers Squibb shares are held by institutional investors. Comparatively, 80.8% of Medtronic shares are held by institutional investors. 0.1% of Bristol-Myers Squibb shares are held by company insiders. Comparatively, 0.3% of Medtronic shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

Medtronic received 505 more outperform votes than Bristol-Myers Squibb when rated by MarketBeat users. Likewise, 76.70% of users gave Medtronic an outperform vote while only 67.08% of users gave Bristol-Myers Squibb an outperform vote.

CompanyUnderperformOutperform
Bristol-Myers SquibbOutperform Votes
1072
67.08%
Underperform Votes
526
32.92%
MedtronicOutperform Votes
1577
76.70%
Underperform Votes
479
23.30%

Bristol-Myers Squibb has a net margin of 18.44% compared to Bristol-Myers Squibb's net margin of 12.83%. Medtronic's return on equity of 51.59% beat Bristol-Myers Squibb's return on equity.

Company Net Margins Return on Equity Return on Assets
Bristol-Myers Squibb18.44% 51.59% 17.03%
Medtronic 12.83%13.73%7.74%

Bristol-Myers Squibb presently has a consensus target price of $63.59, indicating a potential upside of 26.39%. Medtronic has a consensus target price of $93.33, indicating a potential upside of 17.62%. Given Medtronic's higher possible upside, analysts clearly believe Bristol-Myers Squibb is more favorable than Medtronic.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Bristol-Myers Squibb
1 Sell rating(s)
13 Hold rating(s)
4 Buy rating(s)
0 Strong Buy rating(s)
2.17
Medtronic
1 Sell rating(s)
4 Hold rating(s)
6 Buy rating(s)
0 Strong Buy rating(s)
2.45

Bristol-Myers Squibb pays an annual dividend of $2.28 per share and has a dividend yield of 4.5%. Medtronic pays an annual dividend of $2.76 per share and has a dividend yield of 3.5%. Bristol-Myers Squibb pays out 57.9% of its earnings in the form of a dividend. Medtronic pays out 89.9% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future. Bristol-Myers Squibb has raised its dividend for 14 consecutive years and Medtronic has raised its dividend for 47 consecutive years. Bristol-Myers Squibb is clearly the better dividend stock, given its higher yield and lower payout ratio.

Bristol-Myers Squibb has a beta of 0.34, suggesting that its share price is 66% less volatile than the S&P 500. Comparatively, Medtronic has a beta of 0.73, suggesting that its share price is 27% less volatile than the S&P 500.

Summary

Bristol-Myers Squibb beats Medtronic on 11 of the 21 factors compared between the two stocks.


Get Medtronic News Delivered to You Automatically

Sign up to receive the latest news and ratings for MDT and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding MDT and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

MDT vs. The Competition

MetricMedtronicElectromedical equipment IndustryMedical SectorNYSE Exchange
Market Cap$105.51B$3.10B$4.51B$15.79B
Dividend Yield3.47%1.66%2.96%3.67%
P/E Ratio25.8533.65102.2226.19
Price / Sales3.3876.012,638.045.15
Price / Cash10.8612.4684.5217.59
Price / Book2.044.134.056.56
Net Income$3.76B$91.95M$123.82M$900.86M
7 Day Performance-0.80%2.50%1.14%2.63%
1 Month Performance12.27%16.37%11.12%12.83%
1 Year Performance0.97%95.48%8.21%7.28%

Medtronic Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
BMY
Bristol-Myers Squibb
3.3402 of 5 stars
$50.23
+0.5%
$63.59
+26.6%
-36.2%$102.21B$46.16B12.7534,300Dividend Increase
News Coverage
ISRG
Intuitive Surgical
2.7557 of 5 stars
$309.52
-0.7%
$344.14
+11.2%
+14.7%$108.97B$6.85B72.8312,120Positive News
SYK
Stryker
2.9028 of 5 stars
$290.51
-0.2%
$312.17
+7.5%
+18.2%$110.36B$18.45B43.1051,000Dividend Increase
News Coverage
GILD
Gilead Sciences
2.9906 of 5 stars
$79.02
+0.9%
$87.24
+10.4%
-10.2%$98.46B$27.28B16.9617,000
ELV
Elevance Health
2.9377 of 5 stars
$481.94
+0.1%
$565.82
+17.4%
-8.9%$113.24B$156.60B18.92102,300Ex-Dividend
Positive News
SNY
Sanofi
2.382 of 5 stars
$46.34
-1.4%
$60.00
+29.5%
+0.1%$117.22B$45.70B14.5391,573Analyst Downgrade
Analyst Revision
News Coverage
VRTX
Vertex Pharmaceuticals
2.5546 of 5 stars
$354.15
+1.0%
$376.13
+6.2%
+12.1%$91.26B$9.65B26.574,800Analyst Report
News Coverage
REGN
Regeneron Pharmaceuticals
2.2435 of 5 stars
$820.90
-0.3%
$903.52
+10.1%
+12.0%$89.44B$12.17B23.4111,851Analyst Report
News Coverage
ZTS
Zoetis
2.6831 of 5 stars
$179.65
-1.4%
$216.29
+20.4%
+20.3%$82.48B$8.08B36.5113,800Dividend Increase
Analyst Report
News Coverage
Positive News
BSX
Boston Scientific
2.8092 of 5 stars
$54.88
+0.2%
$60.70
+10.6%
+18.9%$80.40B$12.68B66.9345,000News Coverage
Positive News

Related Companies and Tools

This page (NYSE:MDT) was last updated on 12/10/2023 by MarketBeat.com Staff

My Account -